Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC
Clinical trial NCT02992340 · TERMINATED
Trial details
- NCT number
- NCT02992340
- Sponsor
- ASLAN Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-13
- Primary completion
- 2020-06-16
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.